N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide
Title | Journal |
---|---|
Potential for developing purinergic drugs for gastrointestinal diseases. | Inflammatory bowel diseases 20140701 |
Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism. | Clinical and experimental rheumatology 20140101 |